Hypertension may affect tooth-supporting alveolar bone quality: a study in rats

J Periodontol. 2010 Jul;81(7):1075-83. doi: 10.1902/jop.2010.090705.

Abstract

Background: This study evaluates the ligature-induced bone loss (BL) and quality of tooth-supporting alveolar bone in spontaneously hypertensive rats (SHRs) by histometric, histochemical, and immunohistochemical analyses and assesses the effects of lercanidipine on these parameters.

Methods: Wistar rats and SHRs were assigned to one of the following groups: normotensive rats (n = 15), untreated SHRs (n = 15), and treated SHRs (n = 15). The latter group was treated daily with lercanidipine for 45 days. Two weeks after the beginning of drug administration, the first right mandibular molar received a cotton ligature, whereas the contralateral tooth was left unligated. The following parameters were analyzed in the furcation area of decalcified histologic sections: BL, bone density (BD), number of positive cells for tartrate-resistant acid phosphatase (TRAP+), and expression of receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin (OPG).

Results: In ligated teeth, no significant differences among groups were found regarding BL, TRAP+ cells, and the ratio of RANKL/OPG+ cells (P >0.05), although the expression of RANKL was decreased in the treated SHR group (P <0.05). Increased BL and decreased BD were observed around unligated teeth of the untreated and treated SHR groups (P <0.05). In the furcation area of the unligated teeth, the untreated SHR group presented a higher number of TRAP+ cells and higher ratio of RANKL/OPG+ cells compared to the other groups.

Conclusions: SHRs present harmful alterations in the quality of tooth-supporting bone, independently of inflammation. In addition, the administration of lercanidipine for 45 days decreased the expression of bone-resorption markers.

Publication types

  • Comparative Study

MeSH terms

  • Acid Phosphatase / analysis
  • Alveolar Bone Loss / pathology
  • Alveolar Bone Loss / physiopathology
  • Alveolar Process / drug effects
  • Alveolar Process / pathology
  • Alveolar Process / physiopathology*
  • Animals
  • Antihypertensive Agents / therapeutic use
  • Biomarkers / analysis
  • Bone Density / drug effects
  • Bone Density / physiology
  • Dihydropyridines / therapeutic use
  • Hypertension / drug therapy
  • Hypertension / physiopathology*
  • Immunohistochemistry
  • Isoenzymes / analysis
  • Male
  • Molar / pathology
  • Osteoprotegerin / analysis
  • RANK Ligand / analysis
  • Rats
  • Rats, Inbred SHR
  • Rats, Wistar
  • Tartrate-Resistant Acid Phosphatase
  • Tooth Root / pathology

Substances

  • Antihypertensive Agents
  • Biomarkers
  • Dihydropyridines
  • Isoenzymes
  • Osteoprotegerin
  • RANK Ligand
  • Acid Phosphatase
  • Tartrate-Resistant Acid Phosphatase
  • lercanidipine